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Effects of endothelins, which include vasoconstriction and
vasodilatation, are possible by different molecular mechanisms.
Endothelins induce increased synthesis of nitric oxide which in turn
inhibits the synthesis of endothelin. Changes in biochemical
parameters connected with the increased and decreased synthesis of
nitric oxide are not thoroughly examined yet.
In a series of experiments we compared the effects of endothelin
(ET-1) on the inhibition of nitric oxide synthase (NOS), as well as the
effects of L-nitro arginin metal estar (L-NAME) on plasma urea and uric
acid concentration. Experiments were performed on anesthetized
female adult Wistar rats. The experimental groups received an i.v. bolus
of ET-1, L-NAME or saline. All parameters, heamodynamic and
biochemical, were measured before the animals were sacrificed.
L-NAME increased the mean arterial pressure, decreased renal
blood flow and increased vascular resistance in carotid and renal
arteries and increased in plasma uric acid and urea concentrations. ET-
1 significantly decreased uric acid concentration in the plasma but did
not effect plasma urea concentration compared to the control group.
These differences show complex relations of nitric oxide with cellular
signalization compared to the basic NO-cGMP pathway.
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INTRODUCTION
Endothelium as a metabolic and endocrine organ in the body is important in
the modulation of vascular tonus and blood stream. It has synthetic, epicrine,
autocrine and paracrine roles. Endothelial cells synthetize vasorelaxing,
vasoconstricting and thromboresisting substances, as well as a number of
factors and enzymes.
The most potent vasorelaxing mediator was named EDRF and was
identified as endogen NO (Furchgott and Zawadzki, 1980). NO is produced by
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calcium-calmodulin-NADPH dependant synthase which catalyzes the oxidation of
N-guanidine terminal L-Arginine.
There are three types of this enzyme (brain NOS, endothelial NOS, inducible
NOS) (Moncada and Higgs, 1995; Snyder, 1995). L-NAME (L-nitro-arginine methyl
estar) is a blocker of NOS and induces vasoconstriction. NO induces smooth
muscle cells to relax, via cGMP kinase which decreases intracellular Ca2+ level
and relaxes smooth muscle cells by defosforilation of myozin light chains.
The endothelins (ETs) belong to a family of potent vasoconstricting peptides
that were first isolated from vascular endothelial cells in 1988 (Yanagisawa et al.
1988). The three isoforms of ETs (ET1, ET2, ET3) are produced in the renal tissue
(Kohan, 1993).
ET-1 has been described as a very powerful vasoconstricting agent isolated
from vascular endothelium (Battistini et al., 1993). ETs exert their effects via two
types of receptor, classified as ETa and ETb (Chandrashekar et al., 1994). It is well
known that endothelins stimulate endothelial NO synthase which results in
increasing NO concentration as a secondary messenger. Urea is synthesized in
the urea cycle and during NO synthase blockade, urea production decreases.
Uric acid is formed from degradation of purine bases by xanthine oxidase.
The aim of our study was to compare effects of ET-1 and L-NAME on
heamodynamic and biochemical parameters, specially uric acid and urea
concentration changes in Wistar normotensive rats.
MATERIALS AND METHODS
Female Wistar rats, weighting about 200 g, bred at the Institute for Medical
Research, Belgrade were fed on standard chow for laboratory rats (Veterinarski
zavod, Subotica, Serbia and Montenegro). All animal experiments were
conducted in accordance with local institutional guidelines for the care and use of
laboratory animals. The investigation also conformed to the principles and
guidelines of the Canadian council on Animal Care (CCAC). For the treatment of
experimental animals in ous study we used the vasoconstrictor 41199-Endothelin
(rat) 380804, L-NAME as well as saline.
Experimental procedure and groups
All our experiments were performed in anaesthetized (35 mg/kg b.m.
sodium pentobarbital, i.p.) rats. The animals were divided into three groups:
control group (n=10) saline infused, L-NAME (n=10) group (i.v. bolus – 10 mg/kg)
and ET-1 (n=10) group (i.v. bolus – 0.5 mg/kg). Right femoral artery and left
femoral vein were cannulated by poliethylen catheter (PE-50, Clay-Adams,
Parsippany, NJ, USA). Systolic, diastolic blood pressure and heart rate (direct
registrator - Physiograph four, Narco Bio System, Inc) were measured, while
mean blood pressure was calculated by electronic integration. All parameters
were measured before the rats were sacrificed.
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Heamodynamic measurements
The dissolved substances were applied intravenously in a bolus by a
catheter implanted in the left femoral vein. Then mean arterial blood pressure
(MAP) and heart rate were measured. Blood pressure values were measured after
giving anesthesia (MAP1, 2) as well as after the application of tested substances
(MAP 3,4).
For blood flow measurements the carotid and renal arteries were gently
separated. An ultrasonic flow probe (1RB, internal diameter=1 mm) was placed
around the arteries for the measurement of renal blood flow (RBF) and carotid
blood flow (CBF), using a Transonic T106 Small Animal Flowmeter (Transonic
System Inc., Ithaca, NY, USA). Renal vascular resistance (RVR) and carotid
vascular resistance (CVR) were calculated by dividing MAP by renal blood flow
and carotid blood flow (Hg/kg/µL. b.m.).
Biochemical measurements
Before sacrificing the animals we took blood from the abdominal aorta.
Plasma concentration of urea and uric acid were determined by commercial kits
using a spectrophotometer Cobas Mira, Rosh (Elitech Diagnostic).
Statistical analyses
The results are expressed as mean ±SEM. One-way analysis of variance
(ANOVA) was applied. When the ANOVA results were significant, Bonferroni’s t-
test was used to determine level of significance and p value <0,05 was




MAP was significantly increased (p<0.05) in the group infused with L-NAME
compared to the control; ET-1 markedly increased MAP but not significantly
(Fig.1).
Carotid heamodynamic parameters
In the carotid vascular bed MAP and CVR were significantly increased while
CBF was markedly decreased in the L-NAME group compared to the control. ET-1
infused group showed an increase of MAP and CVR but no changes in CBF values
compared to the control group (Fig. 2).
Renal heamodynamic parameters
MAP and RVR were significantly increased and RBF was decreased in L-
NAME group compared to the control. ET-1 group showed no statistical
differences of the same parameters, compared to the control (Fig. 3).
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Figure 1. Mean arterial pressure after substance infusion in experimental groups.




































































Figure 2. Mean arterial pressure, carotid blood flow and carotid vascular resistance (CVR)
in experimental groups.
*p<0.05 compared to control group; n – number of animals
Biochemical parameters
In the L-NAME and ET-1 group plasma urea concentration was significantly
increased compared to the control group (Fig. 4).
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Figure 3. Mean arterial pressure, renal blood flow and renal vascular resistance (RVR) in
experimental groups.





























Figure 4. Plasma urea concentration in experimental groups.
*p<0.05 compared to control group; n – number of animals
Plasma uric concentration was significantly increased in L-NAME group
compared to the control group. ET-1 group showed a significant decrease in the
concentration of plasma uric acid when compared to the control group (Fig 5).
DISCUSSION
Our study showed that a short-time inhibition of nitric oxide biosynthesis
with L-NAME, induces an increase in mean arterial pressure. Regional
heamodynamic responses to inhibition of nitric oxide synthesis showed
decreasing vascular blood flow and increasing vascular resistance in both
examined vascular beds in treated animals.
Acute inhibition of conversion L-arginine into nitric oxide leads to increasing
arterial pressure and TVR as well as decreasing cardiac output (Loeb &
Longnecher, 1992; Rees et al., Wang et al., 1992). Increasing in TVR due to
increasing resistance of many vascular beds including renal (Baylis et al., 1990;
Beierwaltes et al., 1992; Gardiner et al., 1990b; Loeb& Longnecher, 1992; Wang et
al., 1992), mesenteric (Gardiner et al., 1990b), cerebral (Loeb & Wang et al.,
1992), gastric (Pique et al., 1989) and splenic ( Loeb & Longnecher, 1992; Wang et
al., 1992) circulation showed that the increase of resistance is not equal in all
vascular beds.
All of this suggests that nitric oxide has an important role in the distribution
of blood flow. That degree of its influence to a specific flow-resistant domain can
be an indicator of how much the local perfusion in such domain depends on nitric
oxide presence.
In spite of the classical hypothesis in which the cause of hypertension is
perceived in connection to misbalance of vasoconstrictor influences, the new
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Figure 5. Plasma uric acid concentration in experimental groups.
*p<0.05 compared to control group; n – number of animals
concept in the regulation of arterial pressure understands the existence of
balanced synthesis of vasoconstricting and vasodilatating factors (Luscher,
1990). It is well known that endothelin stimulates endothelial NOS which results in
the increase of nitric oxide in the circulation which in turn starts a cascade of
events (NO as a secondary messenger).
Results of our study showed that intravenous infusion of endothelin induced
an initial decrease of arterial blood pressure which soon started to increase and
come to its maximum values ten minutes after infusion. Randy et al. (1996)
showed that ET-1 infusion (0,5 nmol/kg i.v.) in NW rats induced an initial decrease
of arterial blood pressure.
Further examinations of endothelial receptors (ETa & ETb) showed that ETa
receptor blockade induced significant vasodilatation which is reduced by about
95% with simultaneous inhibition of endogenous nitric oxide production. ETb
blockade alone, or with ETa receptor antagonist, induced vasoconstriction and
showed that ETb receptors dominantly interfere ET-1 induced vasodilatation
(Rossi et al., 2001).
Experimental models also assured that ET-1 contributed to the physiological
regulation of vascular tonus by stimulation of nitric oxide production via ETb
receptors. The conclusion was that vasoconstricting effects can be more effective
in reduced nitric oxide activation conditions, such as hypertension and
arteriosclerosis (Rossi et al., 2001). ET-1 interacted with non endothelial
pathways: simpatical system, renin-angiotensin system and CNS. Although in
vitro studies showed interaction of ET-1 in these systems, there is no direct
evidence that ET-1 is involved in hypertension pathogenesis or in vivo vascular
tonus regulation. Several groups which examined hypertension perceived an
increase in ET-1 level during moderate hypertension, while other studies did not
cconfirm such findings (Sitki et al., 1996). There is a conclusion that degradation
of endothelin is tissue specific. Although its metabolism is rapid, endothelin is
either bound to ETa receptor on cells or it interacts with membrane lipids which
have a protective role from protease activation. The later could explain the role of
endothelin as a potent factor in muscle cell contractions (Bermek et al., 1996).
The obtained results clearly demonstrate the difference in plasma uric acid
but not urea concentration between these experimental groups. Endothelin (ET-1)
infusion probably via ETb receptors induces a short time increase in renal blood
flow and consequently the decrease of uric acid concentration due to increased
glomerular filtration rate. The vascular NO-dependant physiological response
may be the consequence of three different molecular events:
– NO stimulation of soluble guanylate cyclase and modulation of
mitochondrial respiration,
– NO induced S-nitrosylation, including inhibition of caspases and
– Intracellular formation of peroxynitrite and the activation of nitrogen-
activated protein kinases (Levonen et al., 2001).
In our experiment we compared the effects of ET-1 induced ETb endothelial
NO production with L-NAME inhibition in NO production and detected opposite
effects on uric acid concentration but not on urea concentration. Although urea
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production should be closely related to NOS activity these differences indicate a
more complex relation of NO with cell signaling than the basic NO-cGMP relation.
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UTICAJ ENDOTELINA I L-NAME NA KONCENTRACIJU MOKRA]NE KISELINE I
UREE U PLAZMI KOD WISTAR PACOVA
POPOVI] TAMARA, JOVOVI] \UR\ICA, MILORADOVI] Z,
MIHAILOVI]-STANOJEVI] NEVENA i SPASI] M
SADR@AJ
Efekti endotelina koji uklju~uju vazokonstrikciju I vazodilataciju ostvaruju se
razli~itim molekularnim mehanizmima. Endotelin indukuje pove}anu sintezu azot-
nog oksida za koji se smatra da povratno inhibira sintezu endotelina. Promene
biohemijskih parametara vezanih za pove}anu i smanjenu sintezu NO nisu dovo-
ljno prou~ene. U ovom radu su upore|eni efekti endotelina (ET-1) i inhibitora
NOS-a, L-NAME na koncentraciju mokra}ne kiseline i uree u plazmi. Eksperimenti
su izvedeni na anesteziranim odraslim NW pacovima, `enskog pola. Eksperimen-
talne `ivotinje su u i.v. bolusu primale ET-1, L-NAME ili fiziolo{ki rastvor. Svi he-
modinamski i biohemijski parametri su mereni pre `rtvovanja. L-NAME dovodi do
pove}anja srednjeg arterijskog pritiska, smanjenja renalnog protoka i pove}anja
vaskularnog otpora u karotidnoj i renalnoj arteriji i pove}anja koncentracije mo-
kra}ne kiseline i uree u plazmi. ET-1 zna~ajno smanjuje koncentraciju mokra}ne
kiseline u plazmi ali ne uti~e na koncentraciju uree u odnosu na kontrolu.
Ove razlike pokazuju kompleksnije relacije NO-a sa }elijskom signalizaci-
jom u odnosu na osnovni NO-cGMP put.
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